Cancer risks for relatives of patients with serrated polyposis

American Journal of Gastroenterology

Volumn 107, Issue 5, 2012, Pages 770-778

  Win, Aung Ko ^a   Walters, Rhiannon J ^b   Buchanan, Daniel D ^b,c   Jenkins, Mark A ^a   Sweet, Kevin ^d   Frankel, Wendy L ^e   De La Chapelle, Albert ^d   McKeone, Diane M ^b   Walsh, Michael D ^b,c   Clendenning, Mark ^b   Pearson, Sally Ann ^b   Pavluk, Erika ^b   Nagler, Belinda ^b   Hopper, John L ^a   Gattas, Michael R ^f   Goldblatt, Jack ^g,h   George, Jill ^h   Suthers, Graeme K ^i,j   Phillips, Kerry D ^j   Woodall, Sonja ^k   Arnold, Julie ^k   Tucker, Kathy ^l   Field, Michael ^m   Greening, Sian ⁿ   Gallinger, Steve ^o,p,q   Aronson, Melyssa ^q   Perrier, Renee ^r   Woods, Michael O ^s   Green, Jane S ^s   Walker, Neal ^t   Rosty, Christophe ^b,c   Parry, Susan ^k,u   Young, Joanne P ^b,c   more..

^a UNIVERSITY OF MELBOURNE   (Australia)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d OHIO STATE UNIVERSITY   (United States)

^e OHIO STATE UNIVERSITY   (United States)

^f ROYAL CHILDREN'S HOSPITAL   (Australia)

^g UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^h Genetic Services of Western Australia   (Australia)

ⁱ UNIVERSITY OF ADELAIDE   (Australia)

^j South Australian Clinical Genetics Service   (Australia)

^k AUCKLAND CITY HOSPITAL   (New Zealand)

^l PRINCE OF WALES HOSPITAL   (Australia)

^m ROYAL NORTH SHORE HOSPITAL   (Australia)

ⁿ WOLLONGONG HOSPITAL   (Australia)

^o CANCER CARE ONTARIO   (Canada)

^p MOUNT SINAI HOSPITAL   (Canada)

^q MOUNT SINAI HOSPITAL   (United States)

^r UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^s MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^t Envoi Pathology   (Australia)

^u MIDDLEMORE HOSPITAL   (New Zealand)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; AUSTRALIA AND NEW ZEALAND; BRAIN CANCER; BREAST CANCER; CANADA; CANCER GENETICS; CANCER PATIENT; CANCER RISK; COHORT ANALYSIS; COLORECTAL CANCER; COLORECTAL POLYP; CONFIDENCE INTERVAL; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PANCREAS CANCER; POLYPOSIS; POPULATION; PRIORITY JOURNAL; PROSTATE CANCER; RELATIVE; RETROSPECTIVE STUDY; SERRATED POLYPOSIS; STANDARDIZED INCIDENCE RATIO; STOMACH CANCER; UNITED STATES; ADENOCARCINOMA; ADENOMA; CLINICAL TRIAL; COLON POLYP; COLORECTAL TUMOR; GENETICS; MIDDLE AGED; MULTICENTER STUDY; NEOPLASM; PANCREAS TUMOR; PATHOLOGY; RISK;

ADENOCARCINOMA; ADENOMA; COLONIC POLYPS; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PANCREATIC NEOPLASMS; RISK;

EID: 84862309400     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2012.52     Document Type: Article

References (45)

1. Snover DC, Ahnen DJ, Burt RW et al. Serrated polyps of the colon and rectum and serrated polyposis. In: Bosman FT, Carneiro F, Hruban RH, et al. (eds). WHO Classification of Tumours of the Digestive System. 4th edn. Lyon, France: IARC, 2010, pp 160-165.
2. Torlakovic E, Snover DC. Serrated adenomatous polyposis in humans. Gastroenterology 1996;110:748-55. (Pubitemid 26071842)
3. Lockett M, Atkin W. Hyperplastic polyposis: prevalence and cancer risk. Gut 2010;48:A4.
4. Boparai KS, Mathus-Vliegen EM, Koornstra JJ et al. Increased colorectal cancer risk during follow-up in patients with hyperplastic polyposis syndrome: a multicentre cohort study. Gut 2010;59:1094-100.
5. Buchanan DD, Sweet K, Drini M e t al. Risk factors for colorectal cancer in patients with multiple serrated polyps: a cross-sectional case series from genetics clinics. PLoS ONE 2010;5:e11636.
6. Carvajal-Carmona LG, Howarth KM, Lockett M et al. Molecular classification and genetic pathways in hyperplastic polyposis syndrome. J Pathol 2007;212:378-85. (Pubitemid 47099014)
7. Hyman NH, Anderson P, Blasyk H. Hyperplastic polyposis and the risk of colorectal cancer. Dis Colon Rectum 2004;47:2101-4. (Pubitemid 40179073)
8. Lage P, Cravo M, Sousa R et al. Management of Portuguese patients with hyperplastic polyposis and screening of at-risk first-degree relatives: a contribution for future guidelines based on a clinical study. Am J Gastroenterol 2004;99:1779-84. (Pubitemid 39237508)
9. Leggett BA, Devereaux B, Biden K et al. Hyperplastic polyposis: association with colorectal cancer. Am J Surg Pathol 2001;25:177-84. (Pubitemid 32167499)
10. Yeoman A, Young J, Arnold J et al. Hyperplastic polyposis in the New Zealand population: a condition associated with increased colorectal cancer risk and European ancestry. N Z Med J 2007;120:U2827.
11. Kalady MF, Jarrar A, Leach B et al. Defining phenotypes and cancer risk in hyperplastic polyposis syndrome. Dis Colon Rectum 2011;54:164-70.
12. Buchanan DD, Sweet K, Drini M et al. Phenotypic diversity in patients with multiple serrated polyps: a genetics clinic study. Int J Colorectal Dis 2010;25:703-12.
13. Chow E, Lipton L, Lynch E et al. Hyperplastic polyposis syndrome: phenotypic presentations and the role of MBD4 and MYH. Gastroenterology 2006;131:30-9. (Pubitemid 44015745)
14. Ferrandez A, Samowitz W, DiSario JA et al. Phenotypic characteristics and risk of cancer development in hyperplastic polyposis: case series and literature review. Am J Gastroenterol 2004;99:2012-8. (Pubitemid 39421248)
15. Williams GT, Arthur JF, Bussey HJ et al. Metaplastic polyps and polyposis of the colorectum. Histopathology 1980;4:155-70. (Pubitemid 10117088)
16. Boparai KS, Reitsma JB, Lemmens V et al. Increased colorectal cancer risk in first-degree relatives of patients with hyperplastic polyposis syndrome. Gut 2010;59:1222-5.
17. Vasen HFA. Clinical diagnosis and management of hereditary colorectal cancer syndromes. J Clin Oncol 2000;18:81s-92.
18. Fearnhead NS, Britton MP, Bodmer WF. The ABC of APC. Hum Mol Genet 2001;10:721-33. (Pubitemid 32331581)
19. Jarrar AM, Church JM, Fay S et al. Is the phenotype mixed or mistaken? Hereditary nonpolyposis colorectal cancer and hyperplastic polyposis syndrome. Dis Colon Rectum 2009;52:1949-55.
20. Vandrovcova J, Lagerstedt-Robinsson K, Pahlman L et al. Somatic BRAFV600E mutations in familial colorectal cancer. Cancer Epidemiol Biomarkers Prev 2006;15:2270-3. (Pubitemid 44877055)
21. Newcomb PA, Baron J, Cotterchio M et al. Colon Cancer Family Registry: an international resource for studies of the genetic epidemiology of colon cancer. Cancer Epidemiol Biomarkers Prev 2007;16:2331-43. (Pubitemid 351196365)
22. Jass JR. Serrated adenoma of the colorectum and the DNA-methylator phenotype. Nat Clin Pract Oncol 2005;2:398-405. (Pubitemid 43115008)
23. Parkin DM, Whelan SL, Ferlay J et al. Cancer Incidence in Five Continents. Vol. VII. IARC: Lyon, France, 1997.
24. Gould W. Jackknife estimation. Stata Technical Bulletin 1995;4:25-9.
25. Baade P, Coory M, Ring I. National Health Priority Cancers in Queensland (1982 to 1997). Health Information Centre, Queensland Cancer Registry: Brisbane, 2000.
26. Ries L, Eisner M, Kosary C et al. SEER Cancer Statistics Review, 1975-2000.
27. National Cancer Institute: Bethesda, MD, 2003.
28. Stata Statistical Soft ware: Release 11. College Station, TX: StataCorp LP;2009.
29. Maul JS, Burt RW, Cannon-Albright LA. A familial component to human rectal cancer, independent of colon cancer risk. Clin Gastroenterol Hepatol 2007;5:1080-4.
30. Wish T, Hyde A, Parfrey P et al. Increased cancer predisposition in family members of colorectal cancer patients harboring the p. V600E BRAF mutation: a population-based study. Cancer Epidemiol Biomarkers Prev 2010;19:1831-9.
31. van Lier MG, Wagner A, Mathus-Vliegen EM et al. High cancer risk in Peutz-Jeghers syndrome: a systematic review and surveillance recommendations. Am J Gastroenterol 2010;105:1258-64; author reply 1265.
32. Lynch HT, Fusaro RM, Lynch JF et al. Pancreatic cancer and the FAMMM syndrome. Fam Cancer 2008;7:103-12.
33. Hruban RH, Canto MI, Goggins M et al. Update on familial pancreatic cancer. Adv Surg 2010;44:293-311.
34. Brune KA, Lau B, Palmisano E et al. Importance of age of onset in pancreatic cancer kindreds. J Natl Cancer Inst 2010;102:119-26.
35. Maisonneuve P, Lowenfels AB. Epidemiology of pancreatic cancer: an update. Dig Dis 2010;28:645-56.
36. Anderson JC, Rangasamy P, Rustagi T et al. Risk factors for sessile serrated adenomas. J Clin Gastroenterol 2011;45:694-9.
37. Canto MI, Goggins M, Yeo CJ et al. Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach. Clin Gastroenterol Hepatol 2004;2:606-21. (Pubitemid 38834045)
38. Young J, Jenkins M, Parry S et al. Serrated pathway colorectal cancer in the population: genetic consideration. Gut 2007;56:1453-9. (Pubitemid 47517843)
39. Vogt S, Jones N, Christian D et al. Expanded extracolonic tumor spectrum in MUTYH-associated polyposis. Gastroenterology 2009;137:1976-85. e10.
40. Win AK, Cleary SP, Dowty JG et al. Cancer risks for monoallelic MUTYH mutation carriers with a family history of colorectal cancer. Int J Cancer 2011;129:2256-62.
41. Win AK, Hopper JL, Jenkins MA. Estimates of familial risks from family data are biased when ascertainment of families is not independent of family history. Gut 2011;60:1162-3.
42. Adelstein BA, Irwig L, Macaskill P et al. Who needs colonoscopy to identify colorectal cancer? Bowel symptoms do not add substantially to age and other medical history. Aliment Pharmacol Ther 2010;32:270-81.
43. Adelstein BA, Macaskill P, Chan SF et al. Most bowel cancer symptoms do not indicate colorectal cancer and polyps: a systematic review. BMC Gastroenterol 2011;11:65.
44. Foo W, Young JM, Solomon MJ et al. Family history? The forgotten question in high-risk colorectal cancer patients. Colorectal Dis 2009;11:450-5.
45. Perea J, Ortiz M, Hidalgo M et al. Importance of family history in colorectal cancer clinical practice. Colorectal Dis 2010;12:606.